Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)

201742 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 28, pp. v616-v616

Field-Weighted Citation Impact: 3.03